Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
BMC Infect Dis ; 21(1): 382, 2021 Apr 26.
Article in English | MEDLINE | ID: mdl-33902480

ABSTRACT

BACKGROUND: The epidemiology and outcomes of COVID-19 patients in Thailand are scarce. METHODS: This retrospective cohort study included adult hospitalized patients who were diagnosed with COVID-19 at Siriraj Hospital during February 2020 to April 2020. RESULTS: The prevalence of COVID-19 was 7.5% (107 COVID-19 patients) among 1409 patients who underwent RT-PCR for SARS-CoV-2 detection at our hospital during the outbreak period. Patients with COVID-19 presented with symptoms in 94.4%. Among the 104 patients who were treated with antiviral medications, 78 (75%) received 2-drug regimen (lopinavir/ritonavir or darunavir/ritonavir plus chloroquine or hydroxychloroquine), and 26 (25%) received a 3-drug regimen with favipiravir added to the 2-drug regimen. Disease progression was observed in 18 patients (16.8%). All patients with COVID-19 were discharged alive. CONCLUSIONS: The prevalence of COVID-19 was 7.5% among patients who underwent RT-PCR testing, and 10% among those having risk factors for COVID-19 acquisition. Combination antiviral therapies for COVID-19 patients were well-tolerated and produced a favorable outcome.


Subject(s)
COVID-19/epidemiology , Adult , Aged , Aged, 80 and over , Amides/therapeutic use , Antiviral Agents/therapeutic use , Chloroquine/therapeutic use , Darunavir/therapeutic use , Disease Progression , Drug Combinations , Female , Hospitals , Hospitals, University , Humans , Hydroxychloroquine/therapeutic use , Lopinavir/therapeutic use , Male , Middle Aged , Pyrazines/therapeutic use , Referral and Consultation , Retrospective Studies , Ritonavir/therapeutic use , Thailand/epidemiology , Treatment Outcome , Young Adult , COVID-19 Drug Treatment
3.
J Glob Antimicrob Resist ; 6: 57-66, 2016 09.
Article in English | MEDLINE | ID: mdl-27530840

ABSTRACT

Antibiotic resistance genes are rapidly spread between pathogens and the normal flora, with plasmids playing an important role in their circulation. This study aimed to investigate antibiotic resistance plasmids in the gut microbiome of hospitalised patients. Stool samples were collected from seven inpatients at Siriraj Hospital (Bangkok, Thailand) and were compared with a sample from a healthy volunteer. Plasmids from the gut microbiomes extracted from the stool samples were subjected to high-throughput DNA sequencing (GS Junior). Newbler-assembled DNA reads were categorised into known and unknown sequences (using >80% alignment length as the cut-off), and ResFinder was used to classify the antibiotic resistance gene pools. Plasmid replicon modules were used for plasmid typing. Forty-six genes conferring resistance to several classes of antibiotics were identified in the stool samples. Several antibiotic resistance genes were shared by the patients; interestingly, most were reported previously in food animals and healthy humans. Four antibiotic resistance genes were found in the healthy subject. One gene (aph3-III) was identified in the patients and the healthy subject and was related to that in cattle. Uncommon genes of hospital origin such as blaTEM-124-like and fosA, which confer resistance to extended-spectrum ß-lactams and fosfomycin, respectively, were identified. The resistance genes did not match the patients' drug treatments. In conclusion, several plasmid types were identified in the gut microbiome; however, it was difficult to link these to the antibiotic resistance genes identified. That the antibiotic resistance genes came from hospital and community environments is worrying.


Subject(s)
Drug Resistance, Multiple, Bacterial/genetics , Gastrointestinal Microbiome , Genes, Bacterial , Plasmids/genetics , Animals , Anti-Bacterial Agents , Cattle , Humans , Inpatients , Metagenomics , Microbial Sensitivity Tests , Sequence Analysis, DNA , Thailand
4.
J Med Assoc Thai ; 96 Suppl 2: S117-23, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23590031

ABSTRACT

OBJECTIVE: To study the recent trend of health-care associated infections (HAIs) across Thailand. MATERIAL AND METHOD: Using the modified international HAI definitions, the investigators conducted a prospective, nationwide, multi-centered survey to determine a 1-day point-prevalence of HAIs among hospitalized patients in the 47 acute care, primary to tertiary hospitals in January 2011. RESULTS: Of total 10,762 patients (female 50.6%, mean age 44.2 +/- 27.3 years) enrolled in the study, 780 had HAIs or the average prevalence of HAIs was 7.3% (range 2.8-8.5%). Highest rates of HAIs were found in other hospitals (other type of tertiary-care facilities), intensive care units and lower respiratory tracts when stratified by type of hospital, unit of service and site of HAIs, respectively. Gram negative bacteria remained predominant among etiologic agents causing HAIs, as in prior studies. Acinetobacter spp., however emerged as the most common organism. At the time of study, 49.3% of all patients received one or more antimicrobial agents. Among the patients with HAIs, cephalosporins were the most commonly used. CONCLUSION: Recently, no significant change on nationwide prevalence and trend of HAIs in Thailand were demonstrated. Notably, Acinetobacter spp. emerged as the most common etiologic agents of HAIs.


Subject(s)
Cross Infection , Adult , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , Female , Humans , Male , Middle Aged , Prevalence , Prospective Studies , Thailand/epidemiology
5.
Influenza Other Respir Viruses ; 7(3): 359-63, 2013 May.
Article in English | MEDLINE | ID: mdl-23043536

ABSTRACT

A serologic study with simultaneous self-administered questionnaire regarding infection control (IC) practices and other risks of influenza A (H1N1) pdm09 (2009 H1N1) infection was performed approximately 1 month after the first outbreak among frontline healthcare professionals (HCPs). Of 256 HCPs, 33 (13%) were infected. Self-reported adherence to IC practices in >90% of exposure events was 82·1%, 73·8%, and 53·5% for use of hand hygiene, masks, and gloves, respectively. Visiting crowded public places during the outbreak was associated with acquiring infection (OR 3·1, P = 0·019). Amongst nurses, exposure to HCPs with influenza-like illness during the outbreak without wearing a mask was the only identified risk factor for infection (OR = 2·3, P = 0·039).


Subject(s)
Antibodies, Viral/blood , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Adult , Attitude of Health Personnel , Disease Outbreaks , Female , Guideline Adherence , Health Personnel/psychology , Humans , Infection Control , Influenza A Virus, H1N1 Subtype/immunology , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/blood , Influenza, Human/psychology , Male , Middle Aged , Self Report , Seroepidemiologic Studies , Surveys and Questionnaires , Thailand/epidemiology , Young Adult
6.
J Med Assoc Thai ; 91(7): 980-8, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18839835

ABSTRACT

BACKGROUND: The authors aimed to compare the bioequivalence and antibacterial activity of a generic meropenem with the original meropenem and studied its preliminary therapeutic outcome. MATERIAL AND METHOD: A randomized, open-label, crossover study was employed to assess the bioequivalence and antibacterial activity. Twenty-six healthy males were recruited at Siriraj Hospital, Thailand and randomized to firstly receive either a single intravenous 30-minute infusion of a generic (Mapenem) or original meropenem (Meronem) and vice versa for the second period. The washout period was one week. Ten milliliters of blood samples were collected before meropenem infusion and at 0, 10, 15, 30, 45, 60, 90, 120, 150, 180, 240, 360, 470 and 480 minutes after the beginning of the drug infusion. Blood samples were coded and separated into plasma and serum samples. Plasma samples were used to determine drug concentrations by HPLC-UV detector and the data were analyzed for Cmax, AUC0-t and AUC0-inf. Serum samples were assayed in triplicate for measuring generic and original meropenems' inhibitory activities of a meropenem-susceptible E. coli ATCC 25922 in the same agar plate. An open-label design was used to preliminarily study of the therapeutic outcome and adverse effects of the generic meropenem in 30 patients. RESULTS: All enrolled twenty-six volunteers completed the whole study. The statistical analysis of 90% confidence interval of Cmax, A UC0-t, and AUC0-inf of the generic and original meropenems were 87.7 to 101.7%, 96.3 to 102.4% and 96.3 to 102.3%, respectively. The results were within the standard range of bioequivalence acceptance criteria (80-125%) and the powers of the test were greater than 80%. Using E. coli ATCC 25922 in the blind assay of serum inhibition activity, the inhibitory zone sizes (mm) of the generic compared to original meropenems were not statistically different with respect to every time points of blood collections (p < 0.05). Correlation of mean values of serum meropenem levels and the widths of inhibitory zone sizes of the same samples collected at the same intervals showed good linear relationship with r = 0.891; R2 = 0.794 (p < 0.01) for the generic meropenem and r = 0.885; R2 = 0.784 (p < 0.01) for the original meropenem. The therapeutic result with the generic meropenem for various indications was successful or improved in 24 cases from 30 cases (80%) and the bacterial cure rate was 23 in 30 clinical isolates (76.7%). Adverse reactions probably related to the study medication were rash and elevated liver enzymes in 1 and 3 patients, respectively, and all resolved spontaneously. CONCLUSION: In the present study, the generic meropenem exhibited indifferent bioequivalence and antibacterial activity compared to the original meropenem. There was also a good correlation between serum levels and inhibitory zone sizes produced by the same serum samples in every periods of blood collection. Clinical efficacy of the generic meropenem was shown to be satisfactory without notable severe adverse reaction.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Drugs, Generic/pharmacokinetics , Thienamycins/therapeutic use , Adult , Area Under Curve , Chromatography, High Pressure Liquid , Cross-Over Studies , Humans , Male , Meropenem , Therapeutic Equivalency , Thienamycins/pharmacokinetics , Thienamycins/pharmacology , Treatment Outcome
7.
J Med Assoc Thai ; 88(3): 335-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15962640

ABSTRACT

This retrospective study was performed to explore the pattern of adult HIV-infected patients admitted to Siriraj Hospital from January 2003 to December 2003 and estimated the economic losses of these patients. Two hundred and forty four medical records were available for review. The proportion of male to female was 2 to 1. Mean age of patients was 36.64 +/- 9.72 years. The mean CD4 count among 112 patients was 82.79 +/- 96.49 cell/mm3. One hundred and twenty four (50.82%) were newly diagnosed of HIV infection. The three most common opportunistic infections were Tuberculosis (42.62%), Pneumocystis carinii pneumonia (14.75%), and cryptococcosis (13.11%). The mean duration of admission was 15.72 +/- 15.11 days. The mean expense per admission was 38,194.58 +/- 32,354.86 Baht. Fifty four patients (22.13%) died during admission. The mean income of these patients was 3,903.5 +/- 3,841.42 baht per month. The estimated economic losses of 54 patients who died during admission including medical care expense and income losses due to premature death was 69,769,739.32 baht. However, the expected medical expense of antiretroviral medications in these 54 patients if they had been diagnosed earlier and their lives had been saved would have been 42,214,608 baht. Therefore, vigorous voluntary counseling and HIV testing in patients aged 13-70 years when they have any risk factors for HIV infection regardless of symptoms might be more cost effective than diagnosis when they get sick.


Subject(s)
Acquired Immunodeficiency Syndrome/economics , Health Care Costs , Acquired Immunodeficiency Syndrome/diagnosis , Acquired Immunodeficiency Syndrome/therapy , Adult , Counseling , Female , HIV Seropositivity/diagnosis , HIV Seropositivity/economics , HIV Seropositivity/therapy , Hospitalization , Humans , Male , Mass Screening , Middle Aged , Retrospective Studies , Risk Factors , Thailand
8.
J Med Assoc Thai ; 88 Suppl 10: S14-25, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16850635

ABSTRACT

OBJECTIVES: To study the antibiotic susceptibility of common community- and hospital-acquired bacteria in Thailand. MATERIAL AND METHOD: Eight common bacterial pathogens were studied in 24 hospitals across Thailand in 2002-2003. Isolates of clinically proven infections were tested for their susceptibility by agar-based disc diffusion method. RESULTS: A total of 9,091 isolates of target bacteria were studied. Community and hospital acquired bacteria accounted for 54.9% and 45.1% respectively. Community acquired Escherichia coli, Klebsiella pneumoniae, Acinetobacter spp., Enterobacter spp., Staphylococcus aureus were more susceptible to antimicrobials compared to hospital acquired strains. The difference in susceptibility of community-acquired vs hospital acquired Pseudomonas aeruginosa, Coagulase-negative staphylococci and Enterococcus spp. was less impressive indicating the spread of hospital strains into the community. Bacteria isolated from the blood stream were more susceptible to antimicrobials compared to those from the lower respiratory tract, urinary tract and surgical sites. Acinetobacter spp. and Enterococcus spp. were less susceptible to antimicrobials compared to others. CONCLUSION: Decreased susceptibility to antimicrobials was found in all bacteria tested. The susceptibility to commonly used antimicrobials of community-acquired bacteria decreased to a critical level indicating the widespread resistant bacteria to the community.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Community-Acquired Infections/epidemiology , Cross Infection/epidemiology , Drug Resistance, Bacterial , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Cross Infection/drug therapy , Cross Infection/microbiology , Humans , Prospective Studies , Thailand/epidemiology
9.
J Med Assoc Thai ; 88 Suppl 10: S31-5, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16850637

ABSTRACT

OBJECTIVES: To assess the prevalence of intestinal pathogens and the effectiveness of an education program in food handlers in a tertiary care hospital. MATERIAL AND METHOD: The prevalence of intestinal pathogens in food handlers was done by stool cultures for bacteria and microscopy for parasites. Treatment was given to those who had a positive stool examination. An education program on the acquisition of the pathogens and their prevention were given by lecture and distribution of handouts. Efficacy of the education program was evaluated by assessing the knowledge and the presence of pathogens before and after the education program. RESULTS: The study was done from January 2002 to March 2004. Risk factors for acquiring intestinal pathogens among food handlers were high regarding education level, housing, food hygiene and personal hygiene. Diarrheal diseases were common in food handlers and their relatives. Before the education program, 40.8% had intestinal pathogens, bacteria and parasites in almost similar proportions. Most common bacteria were Vibrio parahemolyticus, Plesiomonas shigelloides and Salmonella spp.; Blastocystis hominis, Giardia lambria and Endolimax nana were the frequently found intestinal parasites. Food handlers with the pathogens in stool were treated. After the education program subsequent investigation showed a significant reduction in stool pathogens and parasites but their knowledge and hand hygiene practice did not improve. CONCLUSION: The present study showed a high prevalence rate of intestinal pathogens in food handlers of a tertiary care hospital. The education program failed to improve their knowledge and hand hygiene practice for the prevention of the pathogens.


Subject(s)
Cross Infection/prevention & control , Food Handling/methods , Food Service, Hospital , Inservice Training , Intestinal Diseases/epidemiology , Personnel, Hospital/education , Program Evaluation , Adult , Animals , Cross Infection/epidemiology , Cross Infection/microbiology , Cross Infection/parasitology , Health Knowledge, Attitudes, Practice , Humans , Intestinal Diseases/microbiology , Intestinal Diseases/parasitology , Intestinal Diseases/prevention & control , Middle Aged , Prevalence , Professional Competence , Risk Assessment , Risk Factors , Workforce
10.
J Med Assoc Thai ; 88 Suppl 10: S49-53, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16850640

ABSTRACT

OBJECTIVES: To study bacteria from eye lids and conjunctival sac of patients undergoing cataract surgery before and after the application of antiseptics. MATERIAL AND METHOD: Patients undergoing elective cataract extraction in one university hospital were randomly enrolled. Cultures for bacteria and candida were done by swabbing the eye lids before and after cleaning with 4% chlorhexidine gluconate. Subsequently 10% povidone iodine was applied on eye lids and conjunctival sacs. Cultures of specimens from eye lids and conjunctival sac were taken after the application of 10% povidone iodine and at the end of the operation. RESULTS: Fifty-one patients were enrolled. Positive cultures were found in 90.2% and 82.4% before and after cleaning the face with 4% chlorhexidine. After topical application of 10% povidone iodine, only 19.6% had positive cultures from eye lids and conjunctival sac; a significant reduction (p=0.001). At the end of the operation, positive cultures were found from eye lids in 10 patients and from the conjunctival sac in 4 patients. Isolates were skin flora and candida species in 2 patients. None of the patients had endophthalmitis. CONCLUSION: Cleaning eye lids with 4% chlorhexidine followed by applying 10% povidone iodine was effective in decreasing skin flora in cataract surgery. The organisms were not completely eliminated. Postoperative follow-up to detect infectious complications is warranted.


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Cataract Extraction/adverse effects , Chlorhexidine/analogs & derivatives , Conjunctiva/microbiology , Endophthalmitis/drug therapy , Endophthalmitis/prevention & control , Eyelids/microbiology , Povidone-Iodine/therapeutic use , Adult , Aged , Aged, 80 and over , Chlorhexidine/therapeutic use , Female , Humans , Male , Middle Aged , Ophthalmic Solutions , Postoperative Care , Prospective Studies , Time Factors , Treatment Outcome
11.
J Med Assoc Thai ; 88 Suppl 10: S54-8, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16850641

ABSTRACT

OBJECTIVE: To develop a national evidence-based guidelines for the prevention and control of nosocomial infection. MATERIAL AND METHOD: Draft guidelines for the prevention and control of nosocomial infection were developed by the researchers and reviewed by a 10 member panel of experts. The guidelines were modified by brainstorming of 55 practitioners in July 2002. The guidelines were tested for their applicability in 20 hospitals across the country in 2002. The participants gave suggestions on the guidelines which were modified accordingly. The guidelines were finalized by brainstorming of the 55 practitioners in August 2003. RESULTS: National guidelines for the prevention and control of nosocomial infections were developed. Twenty-one topics were included. Modifications of the drafted guidelines were made four times according to the opinions of 10 experts, twice by brainstorming of 55 practitioners and by the suggestions of participants from 20 hospitals where they were tested. The practices in hospitals with different facilities were also suggested in the guidelines. CONCLUSION: National guidelines for prevention and control of nosocomial infection were formulated. Their application for use in every hospital and periodic reviews are expected.


Subject(s)
Cross Infection/prevention & control , Evidence-Based Medicine , Infection Control/standards , Practice Guidelines as Topic , Consensus Development Conferences as Topic , Humans , Infection Control/organization & administration , Thailand
12.
J Med Assoc Thai ; 88 Suppl 10: S65-9, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16850643

ABSTRACT

OBJECTIVES: To study the prevention and treatment of infectious diseases offered to healthcare workers (HCWs) in Thailand. MATERIAL AND METHOD: Data were collected by interviewing in 2002. RESULTS: A total 1,218 HCWs in 33 hospitals were interviewed. Nurses and doctors were the majority group, accounting for 31.5% and 30.5% respectively. Pre-employement health screenings were done by physical examination in 56.0% and chest X-ray in 55.7% and immunization against hepatitis B and tubuculosis were offered in 17.7% and 11.4% respectively. Annual physical examination and chest x-ray were done in 66.3% and 76.9%. Reported infection with hepatitis A hepatitis B, tuberculosis in HCWs were as high as 16.8%, 4.0% and 2.6% respectively. Only 3.5% to 24.3% of HCWs ever read guidelines on the prevention of infection. Existing laws allowed the implementation of prevention, treatment and compensation in case of occupationally acquired infection in HCWs. CONCLUSION: Prevention of infection in HCWs was implemented far below the ideal level. They should be better protected under existing laws.


Subject(s)
Health Personnel , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Occupational Diseases/prevention & control , Occupational Diseases/therapy , Occupational Health Services/supply & distribution , Adult , Health Care Surveys , Humans , Immunization Programs , Mass Screening/methods , Middle Aged , Occupational Health Services/legislation & jurisprudence , Physical Examination , Risk Assessment , Risk Factors , Thailand
13.
J Med Assoc Thai ; 88 Suppl 10: S75-82, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16850645

ABSTRACT

OBJECTIVES: To study the rates of catheter associated urinary tract infection (CAUTI), Ventilator-associated pneumonia (VAP), Central venous catheter blood stream infection (CVCBSI) and surgical site infection (SSI) in Thai hospitals. The rates of the infections will be used as quality indicators. MATERIAL AND METHOD: Active surveillance in 38 hospitals in Thailand during 2003-2004. Risk stratification of NI rates and utilization of devices were calculated. RESULTS: The rates of CAUTI, VAP, CVCBSI and SSI were obtained. Pooled means, and rates of NI at 10, 25, 50, 75 and 90 percentiles were calculated for CAUTI, VAP, CVCBSI. The infection rates were also presented for each type of hospital. The above NI rates were comparable to those reported by the National Nosocomial Infection Surveillance System (NNIS) in the United States. Surgical site infection was studied in 21 procedures with risk index categories 0-2. The rates of SSI in the present study was lower than those in the U.S. study due to different methods of study. CONCLUSION: The risk stratified rates of CAUTI, VAP, CVCBSI and SSI were obtained. They were similar to a larger scale of study in the United States. The NI rates could be used for evaluating the efficacy of NI control in Thai hospitals.


Subject(s)
Cross Infection/epidemiology , Infection Control/standards , Quality Indicators, Health Care , Sentinel Surveillance , Bacteremia/prevention & control , Catheterization, Central Venous/adverse effects , Catheters, Indwelling/microbiology , Cross Infection/microbiology , Cross Infection/prevention & control , Hospitals, Teaching , Humans , Infection Control/organization & administration , Pneumonia/prevention & control , Population Surveillance , Risk Assessment , Risk Factors , Surgical Wound Infection/prevention & control , Thailand/epidemiology , Urinary Tract Infections/prevention & control , Ventilators, Mechanical/microbiology
14.
J Med Assoc Thai ; 88 Suppl 10: S133-9, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16850658

ABSTRACT

OBJECTIVE: To study the bacterial contamination of antiseptics and disinfections in-use and the risk factors for contamination. MATERIAL AND METHOD: Bacterial contamination of antiseptics and disinfectants was done by culturing in-use solutions. Eight commonly used solutions were studied: alcohol 70%, chlorhexidine 4%, and 0.5%, povidone iodine 7.5% and 10%, tincture iodine 1-2%, lysol 2% and sodium hypochlorite 0.5%. RESULTS: The following risk factors for contamination were found : preparation by unskilled personnel, improper containers and prolonged use. Contamination with bacteria were found in 1.8% of 16,142 samples tested Highest rate of contamination was found in Lysol 2%. There was no contamination of povidone iodine 10% and tincture iodine 1-2%. Bacterial contamination of antiseptics and disinfectants was highest in provincial hospitals and was not found in university hospitals. The rates of contamination correlated with the duration of use. Most bacteria isolated were those found in the environment. CONCLUSION: The contamination of in-use antiseptics and disinfectants was as high as 1.8%. Risk factors for contamination were improper preparation and prolonged use.


Subject(s)
Anti-Infective Agents, Local/standards , Disinfectants/standards , Drug Contamination/statistics & numerical data , Drug Packaging/standards , Equipment Contamination/statistics & numerical data , Infection Control , Pharmacy Service, Hospital/standards , Solutions/standards , Anti-Infective Agents, Local/analysis , Antisepsis , Disinfectants/analysis , Disinfection , Drug Compounding , Drug Contamination/prevention & control , Health Care Surveys , Humans , Pilot Projects , Risk Assessment , Risk Factors , Solutions/analysis , Surveys and Questionnaires , Thailand
15.
J Med Assoc Thai ; 87(2): 173-9, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15061301

ABSTRACT

The authors retrospectively reviewed the medical records of HIV/AIDS patients who were admitted to the medical service, Siriraj Hospital from January 1, 2002 through December 31, 2002. Demographics, CD4 lymphocyte counts, discharge diagnoses, the incidence of Pneumocystis carinii pneumonia (PCP), cerebral toxoplasmosis and cryptococcosis in patients who received and did not receive appropriate chemoprophylaxis against those opportunistic infections when indicated, and outcome of the patients were collected. Three hundred medical records of 286 HIV/AIDS patients were available for review. One hundred and seventy two patients (60.1%) were male. Mean age of the patients was 36.8 +/- 9.91 years (range 14-74). The mean CD4 lymphocyte count that was determined in 165 patients was 74.7 +/- 134.21 cells/mm3 (range 0-894). Of the 300 admissions, 36 per cent were newly diagnosed HIV infection. Only 23 (7.7%) patients had received antiretroviral drugs at the time of hospitalization. The leading HIV-related diseases were tuberculosis (29.3%), Pneumocystis carinii pneumonia (18.7%), and cryptococcosis (15.7%). The rest of them included cytomegalovirus diseases (6.3%), lymphoma (6.3%), Salmonella bacteremia (6%), cerebral toxoplasmosis (5.7%), cryptosporidiosis (5.3%), disseminated Mycobacterium avium complex infection (1.0%), extrapulmonary histoplasmosis (1.0%), Candida esophagitis (1.0%), progressive multifocal leukoencephalopathy (1.0%), and rhodococcosis (0.7%). Among those for whom HIV infection was established and chemoprophylaxis for PCP, cerebral toxoplasmosis and cryptococcosis were indicated, 9.8 per cent vs 28.2 per cent, 3.6 per cent vs 5.1 per cent, and 10 per cent vs 15.2 per cent of whom received and did not receive the appropriate chemoprophylaxis developed PCP, cerebral toxoplasmosis and cryptococcosis respectively. One hundred and ninety (63.3%) patients were alive at discharge, 84 (28.0%) had died, 21 (7%) were referred to other hospitals, and 5 (1.7%) left hospital against medical advice. The mortality rate in newly diagnosed HIV and in known HIV without antiretroviral treatment were comparable but much lower in known HIV-infected patients who received antiretroviral therapy. Secondary prevention by detection of HIV-infected patients while they are asymptomatic and providing them with appropriate chemoprophylaxis against specific opportunistic infections as well as appropriate antiretroviral treatment would decrease morbidity, mortality, and improve the quality of life of HIV-infected patients in Thailand.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/prevention & control , HIV Infections/epidemiology , HIV Infections/prevention & control , Primary Prevention/organization & administration , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/prevention & control , Adolescent , Adult , Age Distribution , Aged , Cohort Studies , Communicable Disease Control , Female , Hospitals, Urban , Humans , Incidence , Male , Medical Records , Middle Aged , Prognosis , Retrospective Studies , Risk Factors , Severity of Illness Index , Sex Distribution , Survival Analysis , Thailand/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...